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Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disorder, classified into
sporadic or familial forms and characterized by motor neurons death, muscle atrophy,
weakness, and paralysis. Among the familial cases of ALS, approximately 20% are
caused by dominant mutations in the gene coding for superoxide dismutase (SOD1)
protein. Of note, mutant SOD1 toxicity is not necessarily limited to the central nervous
system. ALS is indeed a multi-systemic and multifactorial disease that affects whole
body physiology and induces severe metabolic changes in several tissues, including
skeletal muscle. Nevertheless, whether alterations in the plasticity, heterogeneity, and
metabolism of muscle fibers are the result of motor neuron degeneration or alternatively
occur independently of it remain to be elucidated. To address this issue, we made
use of a mouse model (MLC/SOD1G93A) that overexpresses the SOD1 mutant gene
selectively in skeletal muscle. We found an alteration in the metabolic properties of
skeletal muscle characterized by alteration in fiber type composition and metabolism.
Indeed, we observed an alteration of muscle glucose metabolism associated with the
induction of Phosphofructokinases and Pyruvate dehydrogenase kinase 4 expression.
The upregulation of Pyruvate dehydrogenase kinase 4 led to the inhibition of Pyruvate
conversion into Acetyl-CoA. Moreover, we demonstrated that the MLC/SOD1G93A
transgene was associated with an increase of lipid catabolism and with the inhibition
of fat deposition inside muscle fibers. All together these data demonstrate that muscle
expression of the SOD1G93A gene induces metabolic changes, along with a preferential
use of lipid energy fuel by muscle fibers. We provided evidences that muscle metabolic
alterations occurred before disease symptoms and independently of motor neuron
degeneration, indicating that skeletal muscle is likely an important therapeutic target
in ALS.
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INTRODUCTION
Amyotrophic Lateral Sclerosis (ALS) is a multi-factorial and multi-systemic disease due to severe
alterations in several tissues and cell compartments, such as motor neurons, glia, and muscle
(Wijesekera and Leigh, 2009). In addition, energy balance is severely compromised in ALS patients,
owing to higher consumption than intake with increased resting energy use, along with abnormal
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lipid metabolism (Kasarskis et al., 1996; Desport et al., 2005;
Dupuis et al., 2008; Bouteloup et al., 2009; Funalot et al., 2009).
Interestingly, while lower body fat represents an ALS
premorbidity factor (Gallo et al., 2013), overweight or obese
people have a lower risk to develop ALS (O’Reilly et al., 2013).
A recent study has pointed out that ALS patients lose weight
about 10 years before motor symptoms (Peter et al., 2017) and
have higher daily energy intake to compensate the higher energy
consumption that has been documented before clinical onset of
the disease (Huisman et al., 2015).
Similar energetic alterations were found in transgenic animal
models of ALS that ubiquitously express the mutant isoform of
the gene coding for superoxide dismutase 1 (SOD1G93A) (Gurney
et al., 1994). Indeed, the SOD1G93A mice are characterized by
increased energy expenditure and by a concomitant skeletal
muscle hypermetabolism (Dupuis et al., 2004). It has been
demonstrated that a diet rich in lipids can delay disease onset
and motor neuron degeneration and can extend life expectancy
of mutant SOD1 mice (Dupuis et al., 2004).
During disease progression and muscle denervation, the
SOD1G93A mice exhibit a loss of fast-twitch glycolytic fibers and
show a transition of skeletal myosin from fast glycolytic type
toward slower oxidative one (Peggion et al., 2017). The loss of fast
glycolytic fibers is considered a consequence of the degeneration
of fast fatigable motor neuron synapsis that leads to a shift in
muscle fiber type. In addition, skeletal muscle of ALS patients and
transgenic ALS mouse models show mitochondrial functional
impairment (Carri and Cozzolino, 2011); this mitochondria
alteration together with increased energy expenditure might
represent one of the first targets of ALS pathology, retrogradely
affecting the nerve in a sort of dying back phenomenon (Shi et al.,
2010).
It has been recently demonstrated, in the muscles of
SOD1G93A mouse model, that the metabolic switch toward
lipid use represents an early pathological event, suggesting that
the metabolic defect is distinct from denervation (Palamiuc
et al., 2015). However, the animal model chosen to conduct
the study did not help to definitely disclose whether muscle
metabolic changes and neuromuscular junction alterations, two
pathogenic events associated with ALS, are a consequence
of changes in synapsis functionality or are independent
of it.
In previous works we have demonstrated that muscle-
selective expression of SOD1 mutation (MLC/SOD1G93A),
induces alterations in the contractile apparatus, and causes
mitochondrial dysfunction without affecting motor neuron
survival (Dobrowolny et al., 2008). Recently, we found a
significant reduced stability of muscles mitochondrial membrane
potential, and we observed a reduced integrity of mitochondrial
network in the region of the Neuromuscular Junctions (NMJ) of
MLC/SOD1G93A transgenic mice, suggesting that mitochondrial
alterations and accumulation of oxidative stress negatively impact
on NMJ stability (Dobrowolny et al., 2018).
Here, taking advantage of MLC/SOD1G93A mice, we
investigated whether muscle specific accumulation of SOD1G93A
can induce metabolic changes that occur independently from
motor neuron degeneration and precede muscle denervation.
MATERIALS AND METHODS
Mice
Four-month-old MLC/SOD1G93A mice overexpressing the
mutant SOD1 gene (SOD1G93A) under the control of the Myosin
Light Chain (MLC) muscle specific promoter (Dobrowolny
et al., 2008) and 4-month-old Friend leukemia virus B (FVB)
(Jackson Laboratories) have been used. Male and female
mice were used indiscriminately. The animals were housed
in a temperature controlled (22◦C) room with a 12:12 h
light–dark cycle and housed in a number of three to five per
cage. All animal experiments were approved by the ethics
committee of Sapienza University of Rome-Unit of Histology
and Medical Embryology and were performed in accordance
with the current version of the Italian Law on the Protection of
Animals.
Histological Analysis
Segments of tibialis anterior (TA) muscles isolated from both
wild type (Wt) and MLC/SOD1G93A transgenic mice were
embedded in tissue freezing medium and snap frozen in
nitrogen-cooled isopentane. Ten µm sections were prepared for
either NADH-transferase or PAS staining. Images were collected
using a Zeiss AX10-Imager A2 connected to the Axiocam 503
color.
RNA Preparation and Real-Time Analysis
Total RNA from Wt and MLC/SOD1G93A transgenic muscles was
isolated from tibialis anterior muscles (TA) by TRIzolTM reagent
(Thermo Fisher Scientific). The yield, quality, and integrity
of RNA were determined using NanoDrop ND-2000 (Thermo
Fisher Scientific).
Total RNA (1 µg) reverse-transcription was performed
using Qiagen Reverse Trascription Kit (Qiagen) whereas
10 ng of RNA was reverse transcribed using the TaqMan
micro-RNA Reverse Transcription Kit (Thermo Fisher
Scientific). Quantitative PCR was performed using the
ABI PRISM 7500 SDS (Thermo Fisher Scientific), TaqMan
universal MMIX II (Thermo Fisher Scientific), and TaqMan
probe (Thermo Fisher Scientific). Quantitative RT-PCR
sample value was normalized for the expression of β-actin
and U6 snRNA for mRNA and microRNA, respectively.
The relative expression was calculated using the 2−11Ct
method (Livak and Schmittgen, 2001) and reported as fold
change.
Protein Extraction and Western Blot
Analysis
Protein extraction from both Wt and MLC/SOD1G93A transgenic
tibialis anterior muscles was performed in Sodium Chloride,
1 mM Phenylmethylsulfonyl fluoride, 1 µg/ml Aprotinin,
1 µg/ml Leupeptin, 1 µg/ml Pepstatin, 1 mM Sodium
orthovanadate, 1 mM Sodium fluoride. Equal amounts of
protein from each muscle lysate were separated in SDS
polyacrylamide gel and transferred onto a nitrocellulose
membrane. Filters were saturated with 5% milk and then blotted
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with antibodies against Slow myosin (1:3000) (Sigma Aldrich,
United States), Glut4 (1:250) (Cell Signaling Technology,
United States), PDH-E1α (pSer300) (1:400) (Calbiochem,
United States and Canada), Pyruvate Dehydrogenase complex
(PDH; 1:600) (Cell Signaling, United States), Phospho-
GSk3β (pSer9) and total GSk-3β (1:1000) (Cell Signaling,
United States), ATGL (1:100) (Cell Signaling, United States),
pACC(1:600) (Cell Signaling, United States), ACC(1:250)
(Cell Signaling, United States), Plin2 (2µg/ml) (Life Span
Biosciences, United States), and α-tubulin (1:2000) (Sigma
Aldrich, United States).
Then, filter was incubated with secondary antibodies Goat
anti-mouse IgG HRP-conjugated (1:7000) (Bethyl, Montgomery,
TX, United States) or Goat anti-rabbit IgG HRP-conjugated
(1:7000) (Bethyl, Montgomery, TX, United States) in 1% milk for
1 h. All the antibodies were chosen as validated for western blot
by manufactures.
Glucose Tolerance Test
Four-month-old Wt and MLC/SOD1G93A transgenic mice were
fasted for 18 h and blood was drawn from a small incision at
the tip of the tail. Blood glucose levels were evaluated using a
commercial Glucose multicare (BSI) kit. Glucose tolerance test
(GTT) was performed measuring glucose before and after IP
injection of 2 g/kg body mass of glucose. Changes in blood
glucose were followed for 120 min with measurements taken
every 30 min.
CARS Microscopy
A multi modal non-linear microscope was used to record 3D
stacks of images in cryosections of muscle tissue, using the
strong CH vibration at 2840 cm−1 of lipids as image contrast.
In brief, a picosecond laser source (Levante Emerald OPO, APE
Angewandte Physik & Elektronik GmbH, Germany, pumped
by an Nd:Vanadate laser at 532 nm, High Q Laser GmbH,
Austria) generated two pulses at 76 MHz repetition rate, with
powers of 50 mW and 120 mW for the pump (817 nm)
and Stokes (1064 nm) beams, respectively, that were spatially
and temporally overlapped and then coupled to a modified
inverted laser scanning confocal microscope (Nunn et al.,
2016).
Statistical Analysis
All details related to statistical tests, statistical parameters,
including sample sizes (n = number of animal subjects per
group), and significance are reported in Figure Legends.
For real-time PCR we considered sample size adequate
when the two groups were significantly different (P < 0.05).
Unless otherwise indicated, P-values for simple pair-wise
comparisons were performed using a two-tailed unpaired and
non-parametric Mann–Whitney test and graph values are
reported as mean± SEM. (error bars).
Data is considered statistically significant when p < 0.05.
Asterisks in figures, indicate statistical significance ∗p < 0.05,
∗∗p< 0.05. All statistical analysis was performed using GraphPad
PRISM 6 software.
RESULTS
MLC/SOD1G93A Mice Exhibit a
Fast-to-Slow Shift in the Fiber Type
Composition
In a previous work we have demonstrated that localized
expression of SOD1G93A promoted the fiber-type switching
from glycolytic toward more oxidative fibers in EDL muscle of
MLC/SOD1G93A mice (St. Pierre et al., 2006). To further support
this evidence, we analyzed NADH levels in the tibialis anterior
(TA) muscle, which contains high proportion of the fastest
glycolytic fibers. Figure 1A shows higher content of NADH in the
TA muscle of MLC/SOD1G93A mice compared to that observed in
the TA of Wt littermates.
To further investigate the metabolic profile of the
MLC/SOD1G93A muscles we assayed the expression of Myosin
Slow type I levels, and we observed a slight increase of Myosin
Slow type I in the transgenic muscles compared to the Wt ones
(Figure 1B and Supplementary Figure S1).
Recent evidences have demonstrated that the nuclear
receptors PPARβ/δ and PPARα play opposing roles upon the
type I fiber specification program, regulating the expression of
two non-coding RNA, MiR-208b, and MiR-499, both activating
a signaling cascade for the expression of muscle slow twitch
contractile proteins (van Rooij et al., 2009). In particular, it has
been demonstrated that genetic ablation of PPARα or the up-
regulation of PPARβ/δ mediated by PGC-1α, lead to significant
accumulation of MiR-208b and MiR-499 and specify for a slow
muscle fiber program (Gan et al., 2013).
We analyzed the expression level of PPARα and MiR-499 in
both Wt and MLC/SOD1G93A (Tg) TA muscles and we observed
a significant down-modulation of PPARα expression levels and
a concomitant up-regulation of MiR-499 (Figures 1C,D) in
MLC/SOD1G93A mice compared to Wt littermates, suggesting
that muscle specific expression of SOD1 mutant gene triggers a
slow-oxidative program mediated by a PGC1α/PPAR dependent
regulatory circuit.
A key regulator of PGC-1α expression is Mef2c, a
transcriptional factor that is responsible for fast-to-slow
switch of muscle fibers (Czubryt et al., 2003). We revealed a
significant increased expression of Mef2C transcript in the
muscle of MLC/SOD1G93A mice compared to that of the Wt
littermates (Figure 1E), confirming the evidences of a metabolic
transition of muscle fibers from glycolytic toward more oxidative
type.
Overall these data indicate that perturbation in redox
signaling cascades, induced by muscle specific expression of
SOD1G93A, promoted a muscle metabolic adaptation in line with
what observed in the skeletal muscle of SOD1G93A mice that
ubiquitously express the mutant SOD1 gene (Palamiuc et al.,
2015).
Muscle Glucose Metabolism Is Altered in
the MLC/SOD1G93A Mice
Glycolysis is a metabolic pathway that converts glucose
into pyruvate, providing high energy substrate. Glycolysis is
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FIGURE 1 | MLC/SOD1G93A mice exhibit a fast-to-slow switch in muscle fiber composition. (A) NADH-TR staining in Wt and Tg TA muscles shows a shift from
glycolitic to oxidative metabolism (darker fibers), Bar, 100 µm. (B) Representative western blot analysis of Myosin type I protein expression in both Wt and Tg mice.
Lower panel shows densitometric analysis for Myosin type I expression relative to α-tubulin in Wt and Tg mice (Wt, Tg n = 5,4). (C–E) Real-time PCR analysis of
miR-499 (C), PPARα (D), Mef2c (E) transcript in Wt and Tg mice [∗p = 0.0177 Wt, Tg n = 7,5 (C); p = 0.0571 Wt, Tg n = 3,4 (D); ∗p = 0.0266 Wt, Tg n = 8,10 (E)].
Data are represented as mean ± SEM. In (B) the lanes were run on the same gel but were non-contiguous.
dysregulated in the animal model of ALS, the SOD1G93A
mice that ubiquitously overexpress the mutant form of the
SOD1 gene (Palamiuc et al., 2015). To verify whether glucose
metabolism was also altered in the MLC/SOD1G93A mice,
we performed the glucose tolerance test, demonstrating that
transgenic mice, compared with Wt littermates, presented higher
blood glucose 60 min after glucose supplementation (Figure 2A).
This suggests that muscle specific expression of SOD1G93A
determines a delay in glucose clearance. To substantiate this
hypothesis, we analyzed the expression levels of Glut-4, a
glucose receptor in muscle fibers, responsible for muscle glucose
uptake. As shown in Figure 2 protein levels of Glut4 was
significantly down-modulated in the MLC/SOD1G93A muscles
(Figure 2B and Supplementary Figure S2), suggesting that
the clearance delay of glucose could mainly be due to a
decreased capacity of transgenic muscle to uptake glucose from
circulation.
Glycolysis is regulated by several enzymes such as the
Hexokinase 2 (HK2) and Phosphofructokinase 1/2, (PFK1, PFK2)
that catalyze, respectively, the first and the second steps of
glycolysis. In the asymptomatic animal model of ALS, the PFK
activity is significantly down-modulated and muscle glucose
metabolism is inhibited (Palamiuc et al., 2015).
To verify whether glycolysis was also altered in the
MLC/SOD1G93A mice, we analyzed the transcription levels of
the Hexokinase 2 (HK2) and Phosphofructokinase 1/2, (PFK1,
PFK2) in TA muscles of transgenic mice. As shown in Figure 2,
differently from that observed in ALS mouse model (Shi et al.,
2010), the glycolytic enzyme was significantly up-regulated in the
muscle of MLC/SOD1G93A mice compared to the Wt littermates
(Figures 2C–E).
Pyruvate is the end product of Glycolysis and its levels are
governed by the PDH that transforms Pyruvate into Acetyl-
CoA. Acetyl-CoA enters the Krebs cycle and produces ATP
and energy fuel for cells through oxidative phosphorylation.
The Pyruvate kinase 4 (PDK4) is a negative regulator of
PDH complex and inhibits PDH activity by phosphorylation
(Denton et al., 1975). To investigate whether Pyruvate is
efficiently converted into Acetyl-CoA we assessed the level
of total and the phosphorylated isoform of PDH and the
levels of PDK4. Interestingly we observed a significant
accumulation of the phosphorylated isoform of PDH and a
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FIGURE 2 | Muscle glucose metabolism is altered in MLC/SOD1G93A mice. (A) Analysis of blood glucose levels in Wt and Tg mice for 120 min (∗∗p < 0.01 Wt, Tg
n = 3,3; Two-way ANOVA test Time p < 0.0001, Interaction p = 0.0003). (B) Representative western blot analysis of Glut4 protein expression in both Wt and Tg
mice. Lower panel shows densitometric analysis for Glut4 expression relative to α-tubulin in Wt and Tg mice (t-test ∗p = 0.0285 Wt, Tg n = 9,12); (C–F) Real-time
PCR analysis of HK2 (C), PFK1 (D), PFK2 (E), PDK4 (F) transcripts in Wt and Tg mice [t-test p = 0.0532 Wt, Tg n = 3,3 (C); p = 0.0571 Wt, Tg n = 4,3 (D);
∗p = 0.0244 Wt, Tg n = 9,9 (E); ∗p = 0.0482 Wt, Tg n = 9,11 (F)]; (G) Representative western blot analysis of pPDH/PDH protein expression in both Wt and Tg mice.
Lower panel shows densitometric analysis for pPDH expression relative to PDH in Wt and Tg mice (t-test ∗p = 0.0261 Wt, Tg n = 5,5); (H) Representative western
blot analysis of PGSK3β and GSK3β protein expression in both Wt and Tg mice. Lower panel shows densitometric analysis for PGSK3β expression relative to total
GSK3β content normalized for protein loading in Wt and Tg mice (t-test ∗p = 0.0476 Wt, Tg n = 10,10); (I) representative microphotographs of PAS staining from Wt
and Tg TA muscles. Bar, 100 µm. (J) Real-time PCR analysis of CS (Wt, Tg n = 4,4). Data are represented as mean ± SEM. In (B,G,H) the lanes were run on the
same gel but were noncontiguous.
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concomitant up-regulation of PDK4, indicating the inhibition
of Acetyl-CoA synthesis (Figures 2F,G and Supplementary
Figure S3). Moreover, as pyruvate accumulation stimulates
the conversion of glucose to glycogen, we assessed the
glycogen synthesis in the MLC/SOD1G93A muscles. We
observed a significant down-modulation of the inhibitory
phosphorylated isoform of the Glycogen Synthase Kinase
3β (GSK3β) and a concomitant increase in intramuscular
glycogen deposition, assayed by Periodic acid-Schiff (PAS)
staining, in the TA muscle of MLC/SOD1G93A mice compared
to that of Wt littermates (Figures 2H,I and Supplementary
Figure S4). Conversely, the mRNA level of Citrate Synthase
(CS), the first enzyme of Krebs cycle, was comparable
between Wt and MLC/SOD1G93A muscles (Figure 2J),
suggesting that alternative catabolic pathway, such as
proteolysis or lipolysis, can guarantee sufficient Acetyl-CoA
synthesis.
Overall these data suggest that muscle restricted expression
of SOD1 mutant gene triggers the activation of the glycolysis
process, which cannot efficiently contribute to oxidative
phosphorylation and energy production.
MLC/SOD1G93A Transgene Is Associated
With the Increase of the Lipid Handling
Pathway
Various factors, including increased fatty acid (FA) use by
β-oxidation, stimulate PDK4 expression (Jeong et al., 2012).
The β-oxidation process is strictly regulated by the levels of its
inhibitor MalonylCoA that is in turn induced by the Acetyl-CoA
carboxylase (ACC). Acetyl-CoA carboxylase strongly controls
lipid synthesis/degradation flux, and its activity is inhibited by
phosphorylation.
To investigate muscle fibers oxidative metabolism, we studied
the expression levels of key proteins of the FA regulation:
CD36, a membrane translocase that promotes FA entry into
the cells, ATGL, a lipase involved in lipid droplet degradation,
and CPT-1B, responsible for the FA transfer into mitochondria.
When compared to Wt littermates, the MLC/SOD1G93A mice
had a significant increase in the expression of all genes studied
(Figures 3A–C and Supplementary Figure S5), including the
pACC/ACC ratio (Figure 3D and Supplementary Figure S6),
suggesting that lipid catabolism is stimulated and lipid synthesis
is inhibited.
Qualitative analysis on lipid droplet accumulation inside
muscle fibers confirmed a preferential use of lipid of the
transgenic muscle. As described in Figure 4 no droplets
were found inside muscle fibers; we observed a significant
accumulation of fat residues just outside muscle fibers
(Figure 4A). Quantitative analysis revealed a significant
up-regulation of lipid droplet volume in the MLC/SOD1G93A
muscle compared to Wt littermates (Figure 4B). This data
was further supported by western blot analysis for Perilipin 2
(PLIN2) expression, a coat protein of lipid droplet. As shown in
Figure 4C we observed a significant up-regulation of Perilipin-2
in MLC/SOD1G93A muscles compared to Wt ones (Figure 4C
and Supplementary Figure S7).
FIGURE 3 | MLC/SOD1G93A mice exhibit an increase of the lipid handling
pathway. (A) Real-time PCR analysis of CD36 transcript in Wt and Tg mice
(Wt, Tg n = 4,4); (B) Representative Western blot analysis of ATGL protein
expression in both Wt and Tg mice. Lower panel shows densitometric
analysis for ATGL expression relative to α-tubulin in Wt and Tg mice
(∗p = 0.0336 Wt, Tg n = 9,12); (C) Real-time PCR analysis of CPT1 transcript
in Wt and Tg mice (∗p = 0.0159 Wt, Tg n = 4,5.) (D) Representative Western
blot analysis of pACC/ACC. Lower panel shows densitometric analysis for
pACC expression relative to ACC in Wt and Tg mice (∗p = 0.0117 Wt, Tg
n = 9,12). Data are represented as mean ± SEM. In (B,D) the lanes were run
on the same gel but were noncontiguous.
These data suggest that muscle specific expression of mutant
SOD1 induces a preferential recruitment of FAs to skeletal muscle
tissue to sustain lipid flux into the skeletal muscle fibers and to
guarantee FAs muscle availability and β-oxidation (Morales et al.,
2017).
DISCUSSION
Our study demonstrates that perturbation in redox signaling
cascades, induced by muscle specific expression of SOD1G93A,
determines a muscle metabolic adaptation towards a more
oxidative metabolism, demonstrating the activation of the slow-
oxidative muscle fiber program and the preferential use of lipid
fuel by the transgenic mice MLC/SOD1G93A.
Interestingly, we observed that muscle metabolic adaptation
to oxidative stress does not involve significant changes in
MyHC expression, in line with previous published works that
have suggested a dissociation between metabolic and contractile
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FIGURE 4 | MLC/SOD1G93A mice exhibit a significant accumulation of fat residues just outside fibers. (A) CARs microscopy analysis shows lipid droplets in EDL
muscles of Tg mice compared to Wt littermates. (B) Analysis of total lipid volume outside fibers in EDL muscle of Wt and Tg mice (∗p = 0.0224 Wt, Tg n. microscope
fields = 4,9). (C) Representative Western blot analysis of PLIN2 in both Wt and Tg mice. Lower panel shows densitometric analysis for PLIN2 expression relative to
α-tubulin in Wt and Tg mice (∗p = 0.0159 Wt, Tg n = 5,5). Data are represented as mean ± SEM. In (C), the lanes were run on the same gel but were noncontiguous.
adaptive response to different stimuli (Schiaffino and Reggiani,
2011). Indeed, it has been demonstrated that moderate endurance
training can induce metabolic changes without concomitant
changes in MyHC composition. Moreover, slow-type electrical
stimulation in rat fast muscles can early abrupt MyHC-2B
to MyHC-2X transcript switch (Kirschbaum et al., 1990), in
response to external stimuli of muscle activity or inactivity
(Ausoni et al., 1990).
Our data support the evidences that metabolic and contractile
properties are controlled by distinct signaling pathways and
provide insight into the mechanism controlling the regulation
of fast-glycolytic and slow-oxidative gene program, induced by
muscle specific expression of SOD1G93A. In particular, among the
possible mechanisms that account for the modulation of different
fast and slow muscle genes, our data support the involvement of
miRNAs hosted in β/slow and slow-tonic Myosin locus.
Recent works have demonstrated that some muscle-specific
microRNAs are located within Myosin genes and thus are co-
expressed with these genes (van Rooij et al., 2009). Among these
microRNAs, miR-499 is located in an intron of Myh7b and targets
a transcriptional repressor of β/slowMyosin, namely Sox6, during
muscle development (van Rooij et al., 2008). Nevertheless, it
remains to elucidate whether muscle-specific miRNAs and Sox6,
controls of fiber type diversification in developing muscle, is also
involved in the maintenance of fiber type properties in adult
skeletal muscle (van Rooij et al., 2009; Gan et al., 2013). Here
we provide evidences that the oxidative insult induced by SOD1
mutant gene expression can determine the modulation of miR-
499 regulative circuit toward a slow muscle fiber program, in
muscle tissue of adult mice.
The shift of muscle fibers, observed in MLC/SOD1G93A
mice, toward the oxidative metabolism might represent a
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compensatory mechanism activated to cope the toxic effects of
mutant SOD1 protein.
In the SOD1G93A mice, which ubiquitously express the
mutant gene (Gurney et al., 1994), the switch toward lipid
use is considered an early sign of disease and occur early
before symptomatic denervation (Palamiuc et al., 2015). It has
been suggested that the early switch of glycolytic fibers toward
oxidative phenotype is due to loss of connections of muscle fibers
to large motoneurons, and to their subsequent reinnervation by
slow motoneurons. Thus, these studies suggest that the oxidative
switch of muscle fibers is a consequence of motor unit alteration,
rather than an intrinsic property of muscle fibers plasticity that
can change the metabolic properties independently from neuron
physiology.
Here, we demonstrate that in the MLC/SOD1G93A fibers, the
metabolic oxidative switch occurs independently from motor
neuron degeneration (Dobrowolny et al., 2018) and along
with neuromuscular instability and deficiency in mitochondrial
chain function (Dobrowolny et al., 2018). Considering the
mitochondria defects and the oxidative damage induced by
muscle specific SOD1 mutant gene expression (Dobrowolny
et al., 2008, 2018), we can speculate that the oxidative change in
energy fuel of MLC/SOD1G93A fibers might reflect an adaptation
to preserve muscle functionality (Blaauw et al., 2013). In
addition, fiber type diversification may also reflect an adaptation
to whole body metabolism and different pattern of activity.
These observations are also in line of recent evidences that
demonstrated how the up-regulation of Mir-499 and Mir-208b
is associated with a reduced atrophy of type I fibers in muscle
biopsies of ALS patients with slow progressive disease (Di Pietro
et al., 2017).
The metabolic shift towards lipid use in the TA muscles
in the ALS mouse model that ubiquitously express the SOD1
mutant gene (Gurney et al., 1994) is accompanied by lower
levels of PFK activity in both presymptomatic and symptomatic
stages of the disease (Palamiuc et al., 2015). These data are
in apparent contrast with the up-regulation of both PFK1
and PFK2 observed in the MLC/SOD1G93A mice. In the ALS
mouse model at the presymptomatic stage of the disease, higher
levels of Pyruvates correlate with a decrease of PFK activity;
conversely at the end stage of the disease low levels of Pyruvate
correlates with low levels of PFK activity, due to the inhibitory
feed-back of Pyruvate. Therefore, although the glycolysis is
enhanced in the MLC/SOD1G93A mice, Pyruvate levels could
be still not sufficient to induce a Pyruvate dependent inhibitory
signal of glucose catabolism. Moreover, Pyruvate can be used in
other compensative pathways that do not involve mitochondria
machinery, such as glycogen synthesis or anaerobic glycolysis.
In conclusion, our data reveal that localized expression
of SOD1G93A induces metabolic changes in skeletal muscle
independently of motor neuron degeneration and further
indicate that skeletal muscle is likely an important target for
therapeutic intervention in ALS.
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